Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens

Carcinogenesis

Volumn 21, Issue 9, 2000, Pages 1761-1765

  Rice, Judd C ^a   Ozcelik, Hilmi ^b,c   Maxeiner, Patrick ^e   Andrulis, Irene ^c,d   Futscher, Bernard W ^a,e  

^a UNIVERSITY OF ARIZONA   (United States)

^b Mount Sinai Hospital   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d CANCER CARE ONTARIO   (Canada)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; BRCA1 PROTEIN; CYTOSINE; MESSENGER RNA;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; FAMILIAL CANCER; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0033857349     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.9.1761     Document Type: Article

References (30)

1. BRCA1 mutations in primary breast and ovarian carcinomas
2. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
3. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region
4. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells
5. BRCA1 expression levels predict distant metastasis of sporadic breast cancers
6. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression
7. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in brca1-associated cases
8. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers
9. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas
10. Growth retardation and tumour inhibition by BRCA1
11. Alterations in DNA methylation: A fundamental aspect of neoplasia
12. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies
13. Selective variegated methylation of the p15 CpG island in acute myeloid leukemia
14. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p/16/CDKN2/MTS1 in human cancers
15. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors
16. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
17. 6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells
18. 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene
19. Methylation of the BRCA1 gene in sporadic breast cancer
20. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics
21. Tumor-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast cancer and ovarian cancer
22. CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site
23. Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers
24. Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene
25. Complex regulation of the BRCA1 gene
26. High sensitivity mapping of methylated cytosines
27. The myb gene family in cell growth, differentiation and apoptosis
28. Arrest of spermatogenesis and defective breast development in mice lacking A-myb
29. Methylation-sensitive DNA binding by v-myb and c-myb proteins
30. CpNpG methylation in mammalian cells